top of page

Pharma Digital Health Commercial Assessment

  • Writer: DTxCC
    DTxCC
  • Feb 5, 2021
  • 1 min read

Updated: Feb 7, 2021


Lupin Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 160 drugs in the United States.

Lupin is interested in entering the digital health / digital therapeutic sector

DTxCC conducts a commercial assessment to develop a clear understanding of the US marketplace and opportunities for a digital health/therapeutic offering

Go-to-market strategies

  • ROI/NPV Investment Evaluation

  • Incremental sales forecast

  • Supporting evidence/promotions needed for commercial success

  • Organizational capabilities needed for commercial success


Komentar


Original.png
  • LinkedIn

DTxCC
Digital Therapeutics Commercialization Consultants

Homestead Drive

West Chester, PA 19382 

Rick@dtxcc.com  |  Tel: 610-533-2118

Privacy Policy

Thanks for submitting!

©2023 by Digital Therapeutics Commercialization Consultants, LLC.

bottom of page